NCT06277869

Brief Summary

Globally, over 15 million neonates are born preterm each year. They account for approximately 30% of global neonatal deaths and 19% of total neonatal deaths in Bangladesh. They usually die because they cannot maintain normal temperature due to their weight, immature skin and underdeveloped thermal regulatory capacity of the brain. Maintaining continuous Kangaroo Mother Care (KMC) for at least 16-20 hours/day, is sometimes not feasible for mothers or caregivers. In addition, we also have the challenge of keeping preterm or low birthweight (LBW) neonates warm during transportation. The scientists at icddr,b, Johns Hopkins University, and George Mason University developed the thermal jacket for keeping preterm or LBW neonate warm. We have already completed the laboratory trial on mannquins and clinical safety trial among preterm or LBW neonates. Now, we propose to build on our previous work by systematically testing the effectiveness trial of the 'thermal jacket' among preterm or LBW neonates at clinical settings. Hypothesis: Thermal jacket can increase the rate of euthermia among the preterm or LBW neonates in the selected health facilities in Bangladesh. Objectives: The aim of this study is to test whether the thermal jacket can attain and maintain euthermia of preterm or LBW neonates in clinical settings of Bangladesh.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 26, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2024

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 7, 2024

Status Verified

March 1, 2024

Enrollment Period

10 months

First QC Date

February 19, 2024

Last Update Submit

March 5, 2024

Conditions

Keywords

Preterm neonateLow birthweight neonateKangaroo Mother CareThermal Jacket

Outcome Measures

Primary Outcomes (1)

  • Body temperature of preterm or low birthweight neonates maintain the euthermic range.

    The primary outcome of this phase is attainment and maintenance of euthermia, defined as i. Having reached to 36.5⁰ C for hypothermic neonates at any point of a single event, ii. Maintaining euthermia throughout the event and iii. Having risen the temperature up to the euthermic range within 1 hour if at any point neonate goes below euthermic range. The endpoint of each event will be ascertained for every neonate during the pre-phase and intervention-phase in the same manner regardless of whether the thermal jacket is used.

    6 hours per event

Study Arms (2)

Thermal Jacket

EXPERIMENTAL

As a intervention, the enrolled preterm or low birthweight neonates gets the thermal jacket as well as Kangaroo Mother Care for thermal care.

Device: Thermal JacketProcedure: Kangaroo Mother Care

Kangaroo Mother Care

ACTIVE COMPARATOR

As a control, the enrolled preterm or low birthweight neonates gets the conventional Kangaroo Mother Care only.

Procedure: Kangaroo Mother Care

Interventions

In the intervention group, the enrolled preterm or low birthweight eligible neonates gets the intervention Thermal Jacket as well as Kangaroo Mother Care.

Thermal Jacket

Skin-to-Skin care, provided by primary caregiver.

Kangaroo Mother CareThermal Jacket

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • KMC eligible neonates
  • Heart rate 100-160 per minute
  • Capillary Refill Time ≤ 3 sec
  • Respiratory rate 30-59 per minute
  • Breaths comfortable
  • Pink in room air

You may not qualify if:

  • In nasogastric tube
  • In oxygen therapy
  • In intravenous fluid
  • Sign of respiratory distress
  • Prolonged or frequent apnea
  • Major surgical problem
  • Gross congenital anomaly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Lakshmipur District Hospital

Lakshmīpur, Chattogram, 3700, Bangladesh

RECRUITING

Kushtia 250 Bedded General Hospital

Kushtia, Khulna Division, 7000, Bangladesh

RECRUITING

Jamalpur 250 Beded General Hospital

Jamālpur, Mymensingh, 2000, Bangladesh

NOT YET RECRUITING

MeSH Terms

Interventions

Kangaroo-Mother Care Method

Intervention Hierarchy (Ancestors)

Patient PositioningPatient CareTherapeuticsInfant CareChild CareHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Anisuddin Ahmed, MS

    International Centre for Diarrhoeal Disease Research, Bangladesh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anisuddin Ahmed, MS

CONTACT

M.A Salam Khan, MS

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: Stepped wedge cluster randomised trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2024

First Posted

February 26, 2024

Study Start

March 1, 2024

Primary Completion

December 22, 2024

Study Completion

December 31, 2024

Last Updated

March 7, 2024

Record last verified: 2024-03

Locations